Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. decreased its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 9.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 826,830 shares of the company's stock after selling 88,725 shares during the period. Dana Investment Advisors Inc. owned approximately 0.96% of Pediatrix Medical Group worth $10,848,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of MD. Rubric Capital Management LP lifted its position in Pediatrix Medical Group by 1.5% during the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after acquiring an additional 125,000 shares in the last quarter. State Street Corp raised its stake in shares of Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock valued at $41,038,000 after purchasing an additional 50,597 shares during the period. Pacer Advisors Inc. purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $35,492,000. Geode Capital Management LLC lifted its position in shares of Pediatrix Medical Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company's stock worth $22,452,000 after purchasing an additional 45,155 shares in the last quarter. Finally, Weiss Asset Management LP boosted its stake in shares of Pediatrix Medical Group by 50.5% in the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock valued at $10,580,000 after purchasing an additional 306,143 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Remove Ads

Pediatrix Medical Group Stock Up 0.9 %

Pediatrix Medical Group stock traded up $0.13 during midday trading on Friday, hitting $14.63. The stock had a trading volume of 661,375 shares, compared to its average volume of 818,968. The business has a fifty day moving average price of $14.08 and a 200 day moving average price of $13.31. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The stock has a market cap of $1.26 billion, a P/E ratio of -12.19, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on MD shares. Macquarie assumed coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price target on the stock. Mizuho lifted their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a research report on Tuesday, November 19th. Truist Financial increased their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Finally, UBS Group upped their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.